Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Oncolytics Bio (ONC.TO)

Oncolytics Bio (ONC.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 142,513
  • Shares Outstanding, K 100,361
  • Annual Sales, $ 0 K
  • Annual Income, $ -31,710 K
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta 0.80
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 23.41
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm -0.37
  • Most Recent Earnings $-0.07 on 08/08/25
  • Next Earnings Date 11/11/25
  • Annual Dividend & Yield 0.00 (N/A)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING TSX Biotechnology

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate -0.08
  • Number of Estimates 1
  • High Estimate -0.08
  • Low Estimate -0.08
  • Prior Year -0.10
  • Growth Rate Est. (year over year) +20.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.13 +25.66%
on 08/08/25
1.68 -15.48%
on 07/23/25
-0.25 (-14.97%)
since 07/22/25
3-Month
0.44 +219.10%
on 06/06/25
1.85 -23.24%
on 07/17/25
+0.86 (+153.57%)
since 05/22/25
52-Week
0.44 +219.10%
on 06/06/25
2.08 -31.73%
on 10/07/24
+0.12 (+9.23%)
since 08/22/24

Most Recent Stories

More News
Biotech Stocks Rally as Oncology Market Targets $866B by 2034

/CNW/ -- Equity Insider News Commentary – Despite alarming federal budget cuts that stand to potentially harm the national battle against cancer, it appears...

ONCY : 0.9700 (+1.68%)
OLMA : 27.45 (-0.80%)
PDSB : 0.8933 (+2.68%)
IOBT : 0.7385 (+5.50%)
ONC.TO : 1.42 (+2.16%)
PRPH : 0.6150 (-10.48%)
Biotech Stocks Rally as Oncology Market Targets $866B by 2034

Equity Insider News Commentary

ONCY : 0.9700 (+1.68%)
OLMA : 27.45 (-0.80%)
PDSB : 0.8933 (+2.68%)
IOBT : 0.7385 (+5.50%)
ONC.TO : 1.42 (+2.16%)
PRPH : 0.6150 (-10.48%)
Cancer Treatment Stocks Surge as $866B Market Attracts Private Investment

/CNW/ -- USA News Group News Commentary – Federal budget cuts have put pressure on cancer research efforts in the United States, but private investment is...

ONCY : 0.9700 (+1.68%)
IOVA : 2.87 (+1.77%)
INO : 2.25 (+4.65%)
ONC.TO : 1.42 (+2.16%)
FATE : 1.0100 (+3.40%)
NKTR : 43.94 (-1.17%)
Cancer Treatment Stocks Surge as $866B Market Attracts Private Investment

USA News Group News Commentary

ONCY : 0.9700 (+1.68%)
IOVA : 2.87 (+1.77%)
INO : 2.25 (+4.65%)
FATE : 1.0100 (+3.40%)
ONC.TO : 1.42 (+2.16%)
NKTR : 43.94 (-1.17%)
FDA Fast-Track Cancer Treatments Drive $900B Market Growth Forecast

Issued on behalf of Oncolytics Biotech Inc. VANCOUVER – Baystreet.ca News Commentary – In the United States, federal budget cuts threaten to slow the nation’s progress in the fight against...

ONCY : 0.9700 (+1.68%)
NUVB : 9.52 (+1.93%)
SANA : 4.53 (unch)
ABSI : 3.56 (+1.14%)
ONC.TO : 1.42 (+2.16%)
IBRX : 2.14 (+1.90%)
Stocks in play: Oncolytics Biotech Inc

Announced the voting results from its Annual General Meeting of Shareholders held on Friday, August ...

ONC.TO : 1.42 (+2.16%)
Oncolytics Biotech® Announces Voting Results from the Annual General Meeting of Shareholders

/CNW/ -- Oncolytics Biotech® Inc. (Nasdaq: ONCY) (TSX: ONC) ("Oncolytics" or the "Corporation" or the "Company"), a clinical-stage immunotherapy company...

ONCY : 0.9700 (+1.68%)
ONC.TO : 1.42 (+2.16%)
Oncolytics Biotech® Announces Voting Results from the Annual General Meeting of Shareholders

SAN DIEGO , Aug. 11, 2025 /PRNewswire/ -- Oncolytics Biotech ®  Inc. (Nasdaq: ONCY) (TSX: ONC) ("Oncolytics" or the "Corporation" or the "Company"), a clinical-stage immunotherapy...

ONCY : 0.9700 (+1.68%)
ONC.TO : 1.42 (+2.16%)
Stocks in play: Oncolytics Biotech Inc

Today reported financial results and recent highlights for the second quarter of 2025. "We have turned ...

ONC.TO : 1.42 (+2.16%)
Oncolytics Biotech® Reports Second Quarter Financial Results and Details Clinical Program Plans for Pelareorep

Key opinion leader event and pancreatic cancer clinical data validate decision to engage with regulators on plans for a registration-enabling study New members...

ONCY : 0.9700 (+1.68%)
ONC.TO : 1.42 (+2.16%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 80% Buy with a Strengthening short term outlook on maintaining the current direction.

See More Share

Business Summary

Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. It is developing pelareorep, an immunotherapeutic agent that improves the...

See More

Key Turning Points

3rd Resistance Point 1.49
2nd Resistance Point 1.47
1st Resistance Point 1.44
Last Price 1.42
1st Support Level 1.39
2nd Support Level 1.37
3rd Support Level 1.34

See More

52-Week High 2.08
Fibonacci 61.8% 1.46
Last Price 1.42
Fibonacci 50% 1.26
Fibonacci 38.2% 1.07
52-Week Low 0.44

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar